BioWorld® - Medical Device Daily
27.11.2012 • Views
Share Embed Flag

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
medicaldevicedaily.com

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

FACILITIES: 258,300 sq. ft. manufacturing facility (for Pharma Division) in the Datong<br />

Economic and Technology Development Zone in Datong City, Shanxi<br />

Province, China<br />

947,200 sq. ft. Chemical and Biotech Division facilities in Datong City<br />

STOCK-FINANCIAL HISTORY: OTC BB--DRUG / TSX--DDD / BBSE--DRP<br />

Net sales $56.245M (YE 05) compared to $29.023M (YE 04)<br />

Net income $182.6K (YE 05) compared to $6.362M (YE 04)<br />

Earnings per share $0.00/share (YE 05) compared to $0.14/share (YE 04)<br />

Average shares outstanding 62.274M (YE 05) compared to 44.502M (YE<br />

04)<br />

Total assets $101.566M (YE 05) compared to $90.338M (YE 04)<br />

SUBSIDIARIES/DIVISIONS: Chemical division--bulk pharmaceutical chemical<br />

Biotech division--recombinant drugs (EPO and G-CSF)<br />

Pharma division--prescription and over-the-counter drugs<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Suzhou Zhongkai commercialization of licensing agreement 2004<br />

Bio-<br />

rhG-CSF worldwide,<br />

Pharmaceuticals<br />

Co. Ltd.<br />

excluding China<br />

PRODUCTS ON MARKET: Prescription and over-the-counter generic drugs<br />

Bulk pharmaceutical chemicals<br />

Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF)<br />

Droycon BioConcepts Inc.<br />

315 Dewdney Avenue<br />

Regina S4N 0E7, Canada<br />

Phone: (306) 585-1762; Fax: (306) 585-3000<br />

Web: www.dbi.sk.ca<br />

E-mail: webman@dbi.ca<br />

KEY PERSONNEL: Dr. D. R. Cullimore; President and CEO<br />

Natalie Ostryznuik; Exec. VP<br />

Vincent Ostryzniuk; Operations Manager<br />

EMPLOYEES: 10 employees<br />

HISTORY: Founded in 1987<br />

STOCK-FINANCIAL HISTORY: Privately held<br />

BUSINESS STRATEGY: Specialize in applied microbial technology used in environmental diagnostics<br />

and bioremediation<br />

Focus on marketing of products and services<br />

RESEARCH & DEVELOPMENT: Microbial technology as applied to biodetection and bioremediation in soil<br />

and waste water<br />

PRODUCTS ON MARKET: BART biodetector systems--portable devices for measuring water filtration<br />

and other properties of soil<br />

BART-READ--computer assisted BART measurement<br />

Copyright ©2006 AHC Media ® 141

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!